Vertex Pharmaceuticals IncorporatedVRTXNASDAQ
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank79
3Y CAGR+9.6%
5Y CAGR+5.3%
Year-over-Year Change
Price-to-earnings ratio
3Y CAGR
+9.6%/yr
vs +2.6%/yr prior
5Y CAGR
+5.3%/yr
Recent acceleration
Acceleration
+7.0pp
Accelerating
Percentile
P79
Within normal range
vs 5Y Ago
1.3x
Solid growth
Streak
1 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 29.32 | +115.1% |
| 2024 | -193.61 | -768.3% |
| 2023 | 28.97 | +30.1% |
| 2022 | 22.26 | -7.9% |
| 2021 | 24.16 | +6.7% |
| 2020 | 22.65 | -52.6% |
| 2019 | 47.77 | +137.7% |
| 2018 | 20.10 | -85.8% |
| 2017 | 141.54 | +188.4% |
| 2016 | -160.15 | - |